selected publications
-
MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab.
Clinical and experimental immunology.
2020
Academic Article
GET IT
Times cited: 32 -
Peri- and Postpartum Management of Patients With Factor XI Deficiency.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
2019
Academic Article
GET IT
Times cited: 6 -
Bleeding Diatheses: Approach to the Patient Who Bleeds or Has Abnormal Coagulation.
Primary care.
2016
Review
GET IT
Times cited: 2 -
Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis: a single-center experience.
Journal of thrombosis and thrombolysis.
2016
Academic Article
GET IT
Times cited: 4 -
Outcomes in Patients With Hemophilia and von Willebrand Disease Undergoing Invasive or Surgical Procedures.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
2016
Academic Article
GET IT
Times cited: 15 -
The safety of chronic antithrombotic therapy in patients with factor XI deficiency.
British journal of haematology.
2016
Letter
GET IT
Times cited: 3 -
Gender and duration of disease differentiate responses to rituximab-dexamethasone therapy in adults with immune thrombocytopenia.
American journal of hematology.
2016
Academic Article
GET IT
Times cited: 32 -
The role of complement activation in thrombosis and hemolytic anemias.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
2016
Review
GET IT
Times cited: 40 -
Management strategies in patients with diffuse large B-cell lymphoma and severe haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia.
2015
Letter
GET IT
Times cited: 1 -
Adherence to guidelines for perioperative management of anticoagulation results in decreased bleeding complications: a single-centre experience.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
2015
Academic Article
GET IT
Times cited: 3 -
Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency.
2015
GET IT
Times cited: 29 -
Fibrinolysis and the control of blood coagulation.
Blood reviews.
2014
Review
GET IT
Times cited: 437 -
Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments.
Clinical advances in hematology & oncology : H&O.
2014
Review
GET IT
Times cited: 37 -
Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
2013
Academic Article
GET IT
Times cited: 12 -
Use of eculizumab in the treatment of a case of refractory, ADAMTS13-deficient thrombotic thrombocytopenic purpura: additional data and clinical follow-up.
British journal of haematology.
2013
Letter
GET IT
Times cited: 38 -
Complement factor H mutations are present in ADAMTS13-deficient, ticlopidine-associated thrombotic microangiopathies.
Blood.
2013
Letter
GET IT
Times cited: 20 -
Combined factor V and factor VIII deficiency: a report of a case, genetic analysis, and response to desmopressin acetate.
2012
GET IT
Times cited: 6 -
Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura.
British journal of haematology.
2012
Letter
GET IT
Times cited: 79